SavedAdd your journal

Journals / Dokuz Eylül Üniversitesi Hemşirelik Fakültesi Elektronik Dergisi / 2020 / Cilt: 13 - Sayı: 3

Oral Mucositis in Patients Undergoing Chemotherapy and Radiotherapy: A Review

Kemoterapi ve Radyoterapi Alan Hastalarda Oral Mukozit: Bir Gözden Geçirme

SEHER ÇAKMAK
Nesrin NURAL
Pages
185–194
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, the definition, epidemiology, developmental mechanism, etiology / risk factors, clinical / economic outcomes, evaluation, prevention/treatment of oral mucositis and the role of nurse will be discussed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Oral mucositis is caused by disruption of oral mucosal integrity following chemotherapy and / or radiotherapy.
📊
Key Findings & Data:Especially head and neck radiotherapy, antimetabolite and alkylating chemotherapy agents cause an increase the frequency and severity of oral mucositis.
💡
Conclusion & Impact:In this review, the definition, epidemiology, developmental mechanism, etiology / risk factors, clinical / economic outcomes, evaluation, prevention/treatment of oral mucositis and the role of nurse will be discussed.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Hematopoetik Kök Hücre Nakli · Kemoterapi · Oral Mukozit

Abstract

Oral mucositis is caused by disruption of oral mucosal integrity following chemotherapy and / or radiotherapy. Especially head and neck radiotherapy, antimetabolite and alkylating chemotherapy agents cause an increase the frequency and severity of oral mucositis. In patients with oral mucositis emerges serious complications such as pain in the mouth / throat, infection and bleeding. It may also have clinical and economic consequences such as deterioration in daily living activities, fluid, nutrient and analgesia support, prolonged hospital stay and increased treatment cost. Many pharmacological and non-pharmacological agents are used in the prevention / treatment of oral mucositis. In this review, the definition, epidemiology, developmental mechanism, etiology / risk factors, clinical / economic outcomes, evaluation, prevention/treatment of oral mucositis and the role of nurse will be discussed.

Özet

Oral mukozit, kemoterapi ve/veya radyoterapiyi takiben oral mukoza bütünlüğünün bozulmasıyla ortaya çıkmaktadır. Özellikle baş-boyun bölgesine uygulanan radyoterapi, antimetabolit ve alkilleyici kemoterapi ajanları oral mukozit sıklığında ve şiddetinde artışa neden olmaktadır. Oral mukozit gelişen hastalarda ağız/boğazda ağrı, enfeksiyon ve kanama gibi ciddi komplikasyonlar ortaya çıkmaktadır. Ayrıca günlük yaşam aktivitelerinde bozulma, sıvı, besin ve analjezi desteği, hastanede yatış süresinin uzaması ve tedavi maliyetinde artış gibi klinik ve ekonomik sonuçları olabilmektedir. Oral mukozitin önlenmesi/tedavisinde farmakolojik ve farmakolojik olmayan birçok ajan kullanılmaktadır. Bu derlemede oral mukozitin tanımı, epidemiyolojisi, gelişme mekanizması, etiyolojisi/risk faktörleri, klinik/ekonomik sonuçları, değerlendirilmesi, önlenmesi/tedavisi ve hemşirenin rolü tartışılacaktır.

🔖

Cite This Article

ÇAKMAK, S., NURAL, N. (2020). Oral Mucositis in Patients Undergoing Chemotherapy and Radiotherapy: A Review. Dokuz Eylül Üniversitesi Hemşirelik Fakültesi Elektronik Dergisi, Cilt: 13 - Sayı: 3, 185–194. https://ajindex.com/articles/149813

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Maria OM, Eliopoulos N, Muanza T. Radiation-induced oral mucositis. Front Oncol 2017;7:89
  2. Chaudhry HM, Bruce AJ, Wolf RC, Litzow MR, Hogan WJ, Patnaik MS, et al. The incidence and severity of oral mucositis among allogeneic hematopoietic stem cell transplantation patients: a systematic review. Biol Blood Marrow Transplant 2016;22(4):605-616
  3. Kamińska M, Juszkiewicz M, Tymicka R, Bronikowska A, Kolak A. Procedure in the prevention and nurturing of inflammatory changes of oral mucositis among patients treated for oncological conditions. Medical Studies/Studia Medyczne. 2016;32(2):145-149
  4. Barkokebas A, Silva IHM, De Andrade SC, Carvalho AAT, Gueiros LAM, Paiva SM, et al. Impact of oral mucositis on oral-health-related quality of life of patients diagnosed with cancer. Journal of Oral Pathology & Medicine. 2015;44(9):746-751
  5. Schub E, Gilberto C. Stomatitis (Oral mucositis), Cancer treatment-induced. Cinahl Information Systems 2017
  6. Wilberg P, Hjermstad MJ, Ottesen S, Herlofson BB. Chemotherapy-associated oral sequelae in patients with cancers outside the head and neck region. J Pain Symptom Manage 2014;48(6):1060-1069
  7. Çakmak S, Nural N. Incidence of and risk factors for development of oral mucositis in outpatients undergoing cancer chemotherapy. Int J Nurs Pract 2019;25(1):e12710
  8. Mercadante S, Aielli F, Adile C, Ferrera P, Valle A, Fusco F, et al. Prevalence of oral mucositis, dry mouth, and dysphagia in advanced cancer patients. Support Care Cancer 2015;23(11):3249-3255
  9. Staudenmaier T, Cenzer I, Crispin A, Ostermann H, Berger K. Burden of oral mucositis in stem cell transplant patients—the patients’ perspective. Support Care Cancer 2018;26(5):1577-1584
  10. Jo KS, Kim NC. Incidence and factors influencing oral mucositis in patients with hematopoietic stem cell transplantation. J Korean Acad Nurs 2014;44(5):542-551
  11. Luitel A, Rimal J, Maharjan IK, Regmee P. Assessment of oral mucositis among patients undergoing radiotherapy for head and neck cancer. Kathmandu Univ Med J 2019;65(1):63-67
  12. Bilodeau EA, Lalla RV. Recurrent oral ulceration: Etiology, classification, management, and diagnostic algorithm. Periodontology 2019;80(1):49-60
  13. Leite Cavalcanti A, José de Macêdo D, Suely Barros Dantas F, dos Santos Menezes K, Filipe Bezerra Silva D, Alves de Melo Junior W, et al. Evaluation of oral mucositis occurrence in oncologic patients under antineoplastic therapy submitted to the low-level laser coadjuvant therapy. J. Clin